A "life-changing" device helped save this Philadelphia-area woman with heart disease

A Philadelphia-area woman is among a growing number of younger women with cardiovascular disease. This device saved her life.
National Institute for Health and Care Excellence

Cardiac contractility modulation device implantation for heart failure

Heart failure is a complex clinical syndrome of symptoms and signs that happen when the heart is not working well enough, leading to reduced blood flow to body tissues. It can lead to oedema in the ...
ktiv

Healthbeat 4: First MercyOne Siouxland patient receives Cardiac Contractility Modulation Therapy procedure

SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...
Seeking Alpha

Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day

COMET-HF, Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil, and AMBER-HFpEF, Phase 2 Clinical Trial of CK-586, Expected to Begin in Q4 AMBER-HFpEF: Phase 2 Clinical Trial of CK-586 ...
BioWorld

AMA panel eyes CPT code for cardiac contractility modulation

The American Medical Association’s CPT editorial panel will meet May 1-3 to consider codes for several devices and services, but the most important of these might be the code for cardiac contractility ...
TCTMD

Real-World Survival Comparison of Symptomatic Patients With Heart Failure Treated With Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
National Institute for Health and Care Excellence

Cardiac contractility modulation device implantation for heart failure

The evidence on cardiac contractility modulation device implantation for heart failure raises no major safety concerns. However, the evidence on efficacy is inadequate in quantity and quality.